Recent clinical studies have shown that the usage of SGLT-2i has cardioprotective advantages. In light of this, recent recommendations urge individuals with type 2 diabetes and concomitant cardiovascular disease to use SGLT-2i as...
Most Recent Articles
Starting SLGT2 Inhibitors Early In Chronic Heart Failure Patients
Acute heart failure (HF) remains to be a particular point of concern among health experts despite advances in medical therapy over the years. Acute HF currently maintains a high rate of morbidity and mortality (Tromp et al, 2020)...
Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): A randomised controlled trial
Lifestyle changes are among some of the easily-mentioned steps in preventing the onset of cardiovascular disease, known to be the leading cause of death around the world. Despite this, many questions surround the aspect of...
VISUALIZED: Single or multiple arterial bypass graft surgery vs. percutaneous coronary intervention in patients with three-vessel or left main coronary artery disease
Read further: Single or multiple arterial bypass graft surgery vs. percutaneous coronary intervention in patients with three-vessel or left main coronary artery disease
Single or multiple arterial bypass graft surgery vs. percutaneous coronary intervention in patients with three-vessel or left main coronary artery disease
The optimal coronary revascularization strategy in left main coronary artery disease (LMCAD) and three-vessel disease (3VD) is highly debatable among medical professionals. Coronary artery bypass grafting (CABG) is demonstrated...